Evine Announces New Fall Lineup
Sep 05, 2017 12:03 pm UTC| Business
MINNEAPOLIS, Sept. 05, 2017 -- Evine Live Inc. (“Evine”) (NASDAQ:EVLV), a multiplatform interactive digital commerce company (evine.com), today announced its fall lineup which includes a number of high-profile launches...
Auris Medical to Host Scientific Symposium at the AAO-HNSF Annual Meeting
Sep 05, 2017 12:01 pm UTC| Business
ZUG, Switzerland, Sept. 5, 2017 -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that...
Sep 05, 2017 12:01 pm UTC| Business
BOSTON, Sept. 05, 2017 -- Keryx Biopharmaceuticals, Inc, (NASDAQ:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced it will webcast corporate...
Atara Biotherapeutics Receives FDA Orphan Drug Designation for ATA230
Sep 05, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 05, 2017 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading "off-the-shelf" T-cell immunotherapy company developing novel treatments for patients with cancer and autoimmune...
Checkpoint Therapeutics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Sep 05, 2017 12:01 pm UTC| Business
NEW YORK, Sept. 05, 2017 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of...
Cynata to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York
Sep 05, 2017 12:01 pm UTC| Business
MELBOURNE, Australia, Sept. 05, 2017 -- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP), announced today it will be featured as a presenting company at the 19th Annual...
Fortress Biotech to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
Sep 05, 2017 12:01 pm UTC| Business
NEW YORK, Sept. 05, 2017 -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today...